﻿<?xml version="1.0" encoding="utf-8"?><affair xmlns:i="http://www.w3.org/2001/XMLSchema-instance"><id>20030310</id><updated>2024-04-10T18:29:15Z</updated><additionalIndexing>2841;Arzneimittelrecht;Arzneikosten;Verkauf mit Preisnachlass;Apotheker/in;reduzierter Preis;Medikament;pharmazeutisches Erzeugnis</additionalIndexing><affairType><abbreviation>Kt. Iv.</abbreviation><id>3</id><name>Standesinitiative</name></affairType><author><canton><abbreviation>VS</abbreviation><id>23</id><name>Wallis</name></canton><type>author</type></author><deposit><date>2003-06-18T00:00:00Z</date><legislativePeriod>46</legislativePeriod><session>4619</session></deposit><descriptors><descriptor><key>L04K01050301</key><name>pharmazeutisches Erzeugnis</name><type>1</type></descriptor><descriptor><key>L05K0105030102</key><name>Medikament</name><type>1</type></descriptor><descriptor><key>L05K0105040101</key><name>Apotheker/in</name><type>1</type></descriptor><descriptor><key>L06K070101020106</key><name>Verkauf mit Preisnachlass</name><type>1</type></descriptor><descriptor><key>L05K0105050101</key><name>Arzneikosten</name><type>1</type></descriptor><descriptor><key>L04K01050502</key><name>Arzneimittelrecht</name><type>2</type></descriptor><descriptor><key>L04K11050412</key><name>reduzierter Preis</name><type>2</type></descriptor></descriptors><drafts><draft><consultation><resolutions><resolution><category><id>3</id><name>Normal</name></category><council><abbreviation>SR</abbreviation><id>2</id><name>Ständerat</name><type>S</type></council><date>2004-03-17T00:00:00Z</date><text>Folge gegeben</text><type>16</type></resolution><resolution><category><id>3</id><name>Normal</name></category><council><abbreviation>NR</abbreviation><id>1</id><name>Nationalrat</name><type>N</type></council><date>2004-10-04T00:00:00Z</date><text>Folge gegeben</text><type>16</type></resolution><resolution><category><id>3</id><name>Normal</name></category><council><abbreviation>SR</abbreviation><id>2</id><name>Ständerat</name><type>S</type></council><date>2005-06-14T00:00:00Z</date><text>Abschreibung</text><type>15</type></resolution><resolution><category><id>3</id><name>Normal</name></category><council><abbreviation>NR</abbreviation><id>1</id><name>Nationalrat</name><type>N</type></council><date>2006-03-22T00:00:00Z</date><text>Die Initiative wird nicht abgeschrieben.</text><type>0</type></resolution><resolution><category><id>3</id><name>Normal</name></category><council><abbreviation>SR</abbreviation><id>2</id><name>Ständerat</name><type>S</type></council><date>2006-12-13T00:00:00Z</date><text>Abschreibung (vgl. Art. 95, Bst. j, Parlamentsgesetz)</text><type>0</type></resolution></resolutions></consultation><federalCouncilProposal /><index>0</index><links /><preConsultations><preConsultation><committee><abbreviation>SGK-SR</abbreviation><id>19</id><name>Kommission für soziale Sicherheit und Gesundheit SR</name><abbreviation1>SGK-S</abbreviation1><abbreviation2>SGK</abbreviation2><committeeNumber>19</committeeNumber><council><abbreviation>SR</abbreviation><id>2</id><name>Ständerat</name><type>S</type></council><typeCode>1</typeCode></committee><date>2003-06-18T00:00:00Z</date><registrations><registration><correspondents /><sessionId>4702</sessionId></registration><registration><correspondents /><sessionId>4714</sessionId></registration><registration><correspondents><correspondent><council><abbreviation>SR</abbreviation><id>2</id><name>Ständerat</name><type>S</type></council><councillor><code>2432</code><gender>f</gender><id>370</id><name>Forster-Vannini Erika</name><officialDenomination>Forster</officialDenomination></councillor><language>de</language></correspondent></correspondents><sessionId>4708</sessionId></registration></registrations><treatmentCategory>IV</treatmentCategory></preConsultation><preConsultation><committee><abbreviation>SGK-NR</abbreviation><id>6</id><name>Kommission für soziale Sicherheit und Gesundheit NR</name><abbreviation1>SGK-N</abbreviation1><abbreviation2>SGK</abbreviation2><committeeNumber>6</committeeNumber><council><abbreviation>NR</abbreviation><id>1</id><name>Nationalrat</name><type>N</type></council><typeCode>1</typeCode></committee><date>2003-06-18T00:00:00Z</date><registrations><registration><correspondents /><sessionId>4711</sessionId></registration><registration><correspondents /><sessionId>4704</sessionId></registration></registrations><treatmentCategory>IV</treatmentCategory></preConsultation></preConsultations><references /><relatedDepartments /><states><state><date>2003-06-18T00:00:00</date><id>24</id><name>Im Rat noch nicht behandelt</name></state><state><date>2004-03-17T00:00:00</date><id>1</id><name>Folge gegeben</name></state><state><date>2004-10-04T00:00:00</date><id>4</id><name>Von beiden Räten behandelt</name></state><state><date>2006-12-13T00:00:00</date><id>4</id><name>Von beiden Räten behandelt</name></state><state><date>2007-06-06T00:00:00</date><id>229</id><name>Erledigt</name></state></states><texts /></draft></drafts><language>de</language><priorityCouncils><priorityCouncil><abbreviation>SR</abbreviation><id>2</id><name>Ständerat</name><type>S</type><priority>1</priority></priorityCouncil></priorityCouncils><relatedAffairs><relatedAffair><id>20063420</id><priorityCode>S</priorityCode><shortId>06.3420</shortId></relatedAffair></relatedAffairs><roles><role><canton><abbreviation>VS</abbreviation><id>23</id><name>Wallis</name></canton><type>author</type></role></roles><sequentialNumber>147</sequentialNumber><shortId>03.310</shortId><state><id>229</id><name>Erledigt</name><doneKey>0</doneKey><newKey>0</newKey></state><texts><text><type><id>5</id><name>Eingereichter Text</name></type><value>&lt;p&gt;Gestützt auf Artikel 160 Absatz 1 der Bundesverfassung reicht der Kanton Wallis der Bundesversammlung folgende Initiative ein:&lt;/p&gt;&lt;p&gt;Artikel 33 des Bundesgesetzes vom 15. Dezember 2000 über Arzneimittel und Medizinprodukte ist mit einem neuen Absatz 4 zu ergänzen, der wie folgt lauten soll:&lt;/p&gt;&lt;p&gt;Art. 33 Abs. 4&lt;/p&gt;&lt;p&gt;Für Apotheken, Drogerien sowie für Krankenanstalten mit einer eigenen pharmazeutischen Versorgung können jedoch Rabatte auf Preise gewährt werden unter der Bedingung, dass sich die bezogenen Rabatte unmittelbar auf die Preise auswirken, welche den Patienten in Rechnung gestellt werden.&lt;/p&gt;</value></text><text><type><id>1</id><name>Titel des Geschäftes</name></type><value>Bundesgesetz über Arzneimittel und Medizinprodukte. Artikel 33</value></text></texts><title>Bundesgesetz über Arzneimittel und Medizinprodukte. Artikel 33</title></affair>